img

Global Crohn’s Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Crohn’s Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Crohn’s Disease Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Crohn’s Disease Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Achieving Remission (The Absence Of Symptoms) and Maintaining Remission (Prevention Of Flare-Ups) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Crohn’s Disease Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Crohn’s Disease Drug key manufacturers include AbbVie, Janssen Biotech, Amgen, Tillotts Pharma and Takeda Pharmaceuticals, etc. AbbVie, Janssen Biotech, Amgen are top 3 players and held % sales share in total in 2022.
Crohn’s Disease Drug can be divided into Aminosalicylates (5-ASA), Corticosteroids, Immunomodulators and Antibiotics, etc. Aminosalicylates (5-ASA) is the mainstream product in the market, accounting for % sales share globally in 2022.
Crohn’s Disease Drug is widely used in various fields, such as Achieving Remission (The Absence Of Symptoms), Maintaining Remission (Prevention Of Flare-Ups) and Pediatric Crohn'S Disease,, etc. Achieving Remission (The Absence Of Symptoms) provides greatest supports to the Crohn’s Disease Drug industry development. In 2022, global % sales of Crohn’s Disease Drug went into Achieving Remission (The Absence Of Symptoms) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Crohn’s Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Janssen Biotech
Amgen
Tillotts Pharma
Takeda Pharmaceuticals
Segment by Type
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics

Segment by Application


Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn'S Disease

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Crohn’s Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Crohn’s Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Crohn’s Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Crohn’s Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Crohn’s Disease Drug introduction, etc. Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Crohn’s Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Crohn’s Disease Drug Market Overview
1.1 Crohn’s Disease Drug Product Overview
1.2 Crohn’s Disease Drug Market Segment by Type
1.2.1 Aminosalicylates (5-ASA)
1.2.2 Corticosteroids
1.2.3 Immunomodulators
1.2.4 Antibiotics
1.3 Global Crohn’s Disease Drug Market Size by Type
1.3.1 Global Crohn’s Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Crohn’s Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Crohn’s Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Crohn’s Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Crohn’s Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Crohn’s Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Crohn’s Disease Drug Market Competition by Company
2.1 Global Top Players by Crohn’s Disease Drug Sales (2018-2024)
2.2 Global Top Players by Crohn’s Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Crohn’s Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Crohn’s Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Crohn’s Disease Drug Market Competitive Situation and Trends
2.5.1 Crohn’s Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Crohn’s Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Crohn’s Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Crohn’s Disease Drug Market
2.8 Key Manufacturers Crohn’s Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Crohn’s Disease Drug Status and Outlook by Region
3.1 Global Crohn’s Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Crohn’s Disease Drug Historic Market Size by Region
3.2.1 Global Crohn’s Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Crohn’s Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Crohn’s Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Crohn’s Disease Drug Forecasted Market Size by Region
3.3.1 Global Crohn’s Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Crohn’s Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Crohn’s Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Crohn’s Disease Drug by Application
4.1 Crohn’s Disease Drug Market Segment by Application
4.1.1 Achieving Remission (The Absence Of Symptoms)
4.1.2 Maintaining Remission (Prevention Of Flare-Ups)
4.1.3 Pediatric Crohn'S Disease
4.2 Global Crohn’s Disease Drug Market Size by Application
4.2.1 Global Crohn’s Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Crohn’s Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Crohn’s Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Crohn’s Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Crohn’s Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Crohn’s Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Crohn’s Disease Drug by Country
5.1 North America Crohn’s Disease Drug Historic Market Size by Country
5.1.1 North America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Crohn’s Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Crohn’s Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Crohn’s Disease Drug Forecasted Market Size by Country
5.2.1 North America Crohn’s Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Crohn’s Disease Drug Sales in Value by Country (2024-2034)
6 Europe Crohn’s Disease Drug by Country
6.1 Europe Crohn’s Disease Drug Historic Market Size by Country
6.1.1 Europe Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Crohn’s Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Crohn’s Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Crohn’s Disease Drug Forecasted Market Size by Country
6.2.1 Europe Crohn’s Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Crohn’s Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Crohn’s Disease Drug by Region
7.1 Asia-Pacific Crohn’s Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Crohn’s Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Crohn’s Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Crohn’s Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Crohn’s Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Crohn’s Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Crohn’s Disease Drug by Country
8.1 Latin America Crohn’s Disease Drug Historic Market Size by Country
8.1.1 Latin America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Crohn’s Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Crohn’s Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Crohn’s Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Crohn’s Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Crohn’s Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Crohn’s Disease Drug by Country
9.1 Middle East and Africa Crohn’s Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Crohn’s Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Crohn’s Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Crohn’s Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Crohn’s Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Crohn’s Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Crohn’s Disease Drug Products Offered
10.1.5 AbbVie Recent Development
10.2 Janssen Biotech
10.2.1 Janssen Biotech Company Information
10.2.2 Janssen Biotech Introduction and Business Overview
10.2.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Janssen Biotech Crohn’s Disease Drug Products Offered
10.2.5 Janssen Biotech Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Amgen Crohn’s Disease Drug Products Offered
10.3.5 Amgen Recent Development
10.4 Tillotts Pharma
10.4.1 Tillotts Pharma Company Information
10.4.2 Tillotts Pharma Introduction and Business Overview
10.4.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Tillotts Pharma Crohn’s Disease Drug Products Offered
10.4.5 Tillotts Pharma Recent Development
10.5 Takeda Pharmaceuticals
10.5.1 Takeda Pharmaceuticals Company Information
10.5.2 Takeda Pharmaceuticals Introduction and Business Overview
10.5.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Takeda Pharmaceuticals Crohn’s Disease Drug Products Offered
10.5.5 Takeda Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Crohn’s Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Crohn’s Disease Drug Industrial Chain Analysis
11.4 Crohn’s Disease Drug Market Dynamics
11.4.1 Crohn’s Disease Drug Industry Trends
11.4.2 Crohn’s Disease Drug Market Drivers
11.4.3 Crohn’s Disease Drug Market Challenges
11.4.4 Crohn’s Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Crohn’s Disease Drug Distributors
12.3 Crohn’s Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Aminosalicylates (5-ASA)
Table 2. Major Company of Corticosteroids
Table 3. Major Company of Immunomodulators
Table 4. Major Company of Antibiotics
Table 5. Global Crohn’s Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Crohn’s Disease Drug Sales by Type (2018-2024) & (K MT)
Table 7. Global Crohn’s Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Crohn’s Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Crohn’s Disease Drug Market Share in Value by Type (2018-2024)
Table 10. Global Crohn’s Disease Drug Price by Type (2018-2024) & (USD/MT)
Table 11. Global Crohn’s Disease Drug Sales by Type (2024-2034) & (K MT)
Table 12. Global Crohn’s Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Crohn’s Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Crohn’s Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Crohn’s Disease Drug Price by Type (2024-2034) & (USD/MT)
Table 16. North America Crohn’s Disease Drug Sales by Type (2018-2024) & (K MT)
Table 17. North America Crohn’s Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Crohn’s Disease Drug Sales (K MT) by Type (2018-2024)
Table 19. Europe Crohn’s Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Crohn’s Disease Drug Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Crohn’s Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Crohn’s Disease Drug Sales (K MT) by Type (2018-2024)
Table 23. Latin America Crohn’s Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Crohn’s Disease Drug Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Crohn’s Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Crohn’s Disease Drug Sales by Company (2018-2024) & (K MT)
Table 27. Global Crohn’s Disease Drug Sales Share by Company (2018-2024)
Table 28. Global Crohn’s Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Crohn’s Disease Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Crohn’s Disease Drug Price by Company (2018-2024) & (USD/MT)
Table 31. Global Crohn’s Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Crohn’s Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Crohn’s Disease Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Crohn’s Disease Drug Market
Table 35. Key Manufacturers Crohn’s Disease Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Crohn’s Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Crohn’s Disease Drug Sales by Region (2018-2024) & (K MT)
Table 39. Global Crohn’s Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Crohn’s Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Crohn’s Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Crohn’s Disease Drug Sales by Region (2024-2034) & (K MT)
Table 44. Global Crohn’s Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Crohn’s Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Crohn’s Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Crohn’s Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Crohn’s Disease Drug Sales by Application (2018-2024) & (K MT)
Table 50. Global Crohn’s Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Crohn’s Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Crohn’s Disease Drug Price by Application (2018-2024) & (USD/MT)
Table 54. Global Crohn’s Disease Drug Sales by Application (2024-2034) & (K MT)
Table 55. Global Crohn’s Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Crohn’s Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Crohn’s Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Crohn’s Disease Drug Price by Application (2024-2034) & (USD/MT)
Table 59. North America Crohn’s Disease Drug Sales by Application (2018-2024) (K MT)
Table 60. North America Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Crohn’s Disease Drug Sales by Application (2018-2024) (K MT)
Table 62. Europe Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Crohn’s Disease Drug Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Crohn’s Disease Drug Sales by Application (2018-2024) (K MT)
Table 66. Latin America Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Crohn’s Disease Drug Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Crohn’s Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Crohn’s Disease Drug Sales by Country (2018-2024) & (K MT)
Table 70. North America Crohn’s Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Crohn’s Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Crohn’s Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Crohn’s Disease Drug Sales by Country (2024-2034) & (K MT)
Table 74. North America Crohn’s Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Crohn’s Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Crohn’s Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Crohn’s Disease Drug Sales by Country (2018-2024) & (K MT)
Table 78. Europe Crohn’s Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Crohn’s Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Crohn’s Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Crohn’s Disease Drug Sales by Country (2024-2034) & (K MT)
Table 82. Europe Crohn’s Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Crohn’s Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Crohn’s Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Crohn’s Disease Drug Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Crohn’s Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Crohn’s Disease Drug Sales by Region (2024-2034) & (K MT)
Table 90. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Crohn’s Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Crohn’s Disease Drug Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Crohn’s Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Crohn’s Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Crohn’s Disease Drug Sales by Country (2024-2034) & (K MT)
Table 98. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Crohn’s Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Crohn’s Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Crohn’s Disease Drug Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Crohn’s Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Crohn’s Disease Drug Sales by Country (2024-2034) & (K MT)
Table 106. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Crohn’s Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 109. AbbVie Company Information
Table 110. AbbVie Introduction and Business Overview
Table 111. AbbVie Crohn’s Disease Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. AbbVie Crohn’s Disease Drug Product
Table 113. AbbVie Recent Development
Table 114. Janssen Biotech Company Information
Table 115. Janssen Biotech Introduction and Business Overview
Table 116. Janssen Biotech Crohn’s Disease Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Janssen Biotech Crohn’s Disease Drug Product
Table 118. Janssen Biotech Recent Development
Table 119. Amgen Company Information
Table 120. Amgen Introduction and Business Overview
Table 121. Amgen Crohn’s Disease Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Amgen Crohn’s Disease Drug Product
Table 123. Amgen Recent Development
Table 124. Tillotts Pharma Company Information
Table 125. Tillotts Pharma Introduction and Business Overview
Table 126. Tillotts Pharma Crohn’s Disease Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Tillotts Pharma Crohn’s Disease Drug Product
Table 128. Tillotts Pharma Recent Development
Table 129. Takeda Pharmaceuticals Company Information
Table 130. Takeda Pharmaceuticals Introduction and Business Overview
Table 131. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Takeda Pharmaceuticals Crohn’s Disease Drug Product
Table 133. Takeda Pharmaceuticals Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Crohn’s Disease Drug Market Trends
Table 137. Crohn’s Disease Drug Market Drivers
Table 138. Crohn’s Disease Drug Market Challenges
Table 139. Crohn’s Disease Drug Market Restraints
Table 140. Crohn’s Disease Drug Distributors List
Table 141. Crohn’s Disease Drug Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Crohn’s Disease Drug Product Picture
Figure 2. Global Crohn’s Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Crohn’s Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Crohn’s Disease Drug Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Aminosalicylates (5-ASA)
Figure 6. Global Aminosalicylates (5-ASA) Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Corticosteroids
Figure 8. Global Corticosteroids Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Immunomodulators
Figure 10. Global Immunomodulators Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Antibiotics
Figure 12. Global Antibiotics Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Global Crohn’s Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Crohn’s Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Crohn’s Disease Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Crohn’s Disease Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Crohn’s Disease Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Crohn’s Disease Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Crohn’s Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Crohn’s Disease Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Crohn’s Disease Drug Revenue in 2022
Figure 27. Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Achieving Remission (The Absence Of Symptoms)
Figure 29. Global Achieving Remission (The Absence Of Symptoms) Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Maintaining Remission (Prevention Of Flare-Ups)
Figure 31. Global Maintaining Remission (Prevention Of Flare-Ups) Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Pediatric Crohn'S Disease
Figure 33. Global Pediatric Crohn'S Disease Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Crohn’s Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Crohn’s Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Crohn’s Disease Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Crohn’s Disease Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Crohn’s Disease Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Crohn’s Disease Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Crohn’s Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Crohn’s Disease Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Crohn’s Disease Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Crohn’s Disease Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Crohn’s Disease Drug Manufacturing Cost Structure
Figure 47. Crohn’s Disease Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries